Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Cizzle Biotech (CIZ)

Price 1.725p on 05-02-2025 at 14:15:03
Change 0.00p 0%
Buy 1.80p
Sell 1.65p
Buy / Sell CIZ Shares
Last Trade: Sell 39,623.00 at 1.668p
Day's Volume: 259,654
Last Close: 1.725p
Open: 1.725p
ISIN: GB00BNG2VN02
Day's Range 1.725p - 1.725p
52wk Range: 1.45p - 2.75p
Market Capitalisation: £7m
VWAP: 1.673936p
Shares in Issue: 396m

Recent Trades History Cizzle Biotech (CIZ)

Buy/Sell Volume Trade Prc Trade Type Trade Time
Sell* 39,623 1.668p Ordinary
14:15:02 - 05-Feb-25
Sell* 590 1.66p Ordinary
13:35:48 - 05-Feb-25
Sell* 12,999 1.66p Ordinary
13:35:06 - 05-Feb-25
Sell* 42,683 1.668p Ordinary
12:19:26 - 05-Feb-25
Sell* 72,516 1.6713p Ordinary
12:18:05 - 05-Feb-25
Buy* 11,243 1.77p Ordinary
10:10:52 - 05-Feb-25
Sell* 80,000 1.6713p Ordinary
09:54:12 - 05-Feb-25
Unknown* 500,000 1.725p Ordinary
15:01:50 - 04-Feb-25
Unknown* -500,000 1.725p Ordinary
Correction
15:01:50 - 04-Feb-25

Share Price History for Cizzle Biotech

Time period:
to
Date Open High Low Close Volume

Share News for Cizzle Biotech

IN BRIEF: Cizzle Biotechnology appoints Founder Dawn Coverley as CSO

2nd Jan 2025 14:29

Cizzle Biotechnology Holdings PLC - London-based life sciences company engaged in developing a blood test for the early detection of the different forms of lung cancer - Appoints Founder & Non-Executive Director Dawn Coverley as chief scientific officer, effective immediately. Says the new role replaces her position as a NED and accelerates its global licensing and partnership strategy to bring its non-invasive, cost effective, CIZ1B biomarker lung cancer blood test to market in 2025. Read More

EARNINGS: Alliance Pharma swings to profit; DG Innovate loss widens

30th Sep 2024 18:37

(Alliance News) - The following is a round-up of earnings for London-listed companies, issued on Monday and not separately reported by Alliance News: Read More

TRADING UPDATES: Light Science Technologies wins two new contracts

9th Sep 2024 22:03

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News: Read More

UK shareholder meetings calendar - next 7 days

17th Jun 2024 15:53

Read More

Cizzle says CIZ1B biomarker test picked for "major" US cancer study

17th Jun 2024 13:33

(Alliance News) - Cizzle Biotechnology Holdings PLC on Monday announced that its proprietary test for the CIZ1B biomarker has been chosen as part of "an important clinical study" at a "leading" US cancer centre. Read More

FTSE 100 Latest
Value8,603.51
Change32.74

Login to your account

Forgot Password?

Not Registered